Medical affairs has the medical and scientific knowledge that pharma companies need as well as the direct relationships with health care practitioners (HCPs), key opinion leaders and other important stakeholders. But most medical affairs departments are challenged, both organizationally and from a capability perspective, to systematically take on expanded responsibilities in areas such as clinical trial design, patient recruitment, health economics and outcomes research (HEOR), and patient engagement. These responsibilities are particularly challenging as they require cooperation with an expanded set of stakeholders.
Written By
There was broad consensus among roundtable participants that the medical affairs function has evolved beyond its traditional role that primarily...
